176 related articles for article (PubMed ID: 21959060)
1. Seropositivity is associated with insulin resistance in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR): an observational study.
Mirjafari H; Farragher TM; Verstappen SM; Yates A; Bunn D; Marshall T; Lunt M; Symmons DP; Bruce IN
Arthritis Res Ther; 2011; 13(5):R159. PubMed ID: 21959060
[TBL] [Abstract][Full Text] [Related]
2. N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR).
Mirjafari H; Welsh P; Verstappen SM; Wilson P; Marshall T; Edlin H; Bunn D; Chipping J; Lunt M; Symmons DP; Sattar N; Bruce IN
Ann Rheum Dis; 2014 Apr; 73(4):684-90. PubMed ID: 23511225
[TBL] [Abstract][Full Text] [Related]
3. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort.
Goodson NJ; Symmons DP; Scott DG; Bunn D; Lunt M; Silman AJ
Arthritis Rheum; 2005 Aug; 52(8):2293-9. PubMed ID: 16052597
[TBL] [Abstract][Full Text] [Related]
4. Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register.
Humphreys JH; Verheul MK; Barton A; MacGregor AJ; Lunt M; Toes RE; Symmons DP; Trouw LA; Verstappen SM
Ann Rheum Dis; 2016 Jun; 75(6):1139-44. PubMed ID: 26443608
[TBL] [Abstract][Full Text] [Related]
5. Using lifestyle factors to identify individuals at higher risk of inflammatory polyarthritis (results from the European Prospective Investigation of Cancer-Norfolk and the Norfolk Arthritis Register--the EPIC-2-NOAR Study).
Lahiri M; Luben RN; Morgan C; Bunn DK; Marshall T; Lunt M; Verstappen SM; Symmons DP; Khaw KT; Wareham N; Bruce IN
Ann Rheum Dis; 2014 Jan; 73(1):219-26. PubMed ID: 23505230
[TBL] [Abstract][Full Text] [Related]
6. Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients.
Goodson NJ; Wiles NJ; Lunt M; Barrett EM; Silman AJ; Symmons DP
Arthritis Rheum; 2002 Aug; 46(8):2010-9. PubMed ID: 12209502
[TBL] [Abstract][Full Text] [Related]
7. Rheumatoid factor and anti-citrullinated protein antibody positivity, but not level, are associated with increased mortality in patients with rheumatoid arthritis: results from two large independent cohorts.
Humphreys JH; van Nies JA; Chipping J; Marshall T; van der Helm-van Mil AH; Symmons DP; Verstappen SM
Arthritis Res Ther; 2014 Dec; 16(6):483. PubMed ID: 25471696
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients.
Goodson NJ; Brookhart AM; Symmons DP; Silman AJ; Solomon DH
Ann Rheum Dis; 2009 Mar; 68(3):367-72. PubMed ID: 18408253
[TBL] [Abstract][Full Text] [Related]
9. The Norfolk Arthritis Register (NOAR).
Symmons DP; Silman AJ
Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S94-9. PubMed ID: 14969058
[TBL] [Abstract][Full Text] [Related]
10. Influence of inflammatory polyarthritis on quantitative heel ultrasound measurements.
Pye SR; Marshall T; Gaffney K; Luben R; Khaw KT; Silman AJ; Symmons DP; O'Neill TW
BMC Musculoskelet Disord; 2012 Jul; 13():133. PubMed ID: 22834652
[TBL] [Abstract][Full Text] [Related]
11. The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register.
Plant D; Thomson W; Lunt M; Flynn E; Martin P; Eyre S; Farragher T; Bunn D; Worthington J; Symmons D; Barton A
Rheumatology (Oxford); 2011 Jan; 50(1):78-84. PubMed ID: 20219786
[TBL] [Abstract][Full Text] [Related]
12. Association of morbid obesity with disability in early inflammatory polyarthritis: results from the Norfolk Arthritis Register.
Humphreys JH; Verstappen SM; Mirjafari H; Bunn D; Lunt M; Bruce IN; Symmons DP
Arthritis Care Res (Hoboken); 2013 Jan; 65(1):122-6. PubMed ID: 22556112
[TBL] [Abstract][Full Text] [Related]
13. The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis.
Naz SM; Farragher TM; Bunn DK; Symmons DP; Bruce IN
Arthritis Rheum; 2008 Apr; 58(4):985-9. PubMed ID: 18383358
[TBL] [Abstract][Full Text] [Related]
14. Erosions in inflammatory polyarthritis are symmetrical regardless of rheumatoid factor status: results from a primary care-based inception cohort of patients.
Bukhari M; Lunt M; Harrison BJ; Scott DG; Symmons DP; Silman AJ
Rheumatology (Oxford); 2002 Mar; 41(3):246-52. PubMed ID: 11934959
[TBL] [Abstract][Full Text] [Related]
15. Twenty-Year Outcome and Association Between Early Treatment and Mortality and Disability in an Inception Cohort of Patients With Rheumatoid Arthritis: Results From the Norfolk Arthritis Register.
Gwinnutt JM; Symmons DPM; MacGregor AJ; Chipping JR; Marshall T; Lunt M; Verstappen SMM
Arthritis Rheumatol; 2017 Aug; 69(8):1566-1575. PubMed ID: 28425173
[TBL] [Abstract][Full Text] [Related]
16. Association of anti-carbamylated protein antibodies with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register.
Humphreys J; Verheul M; Barton A; Fu B; Toes R; Symmons D; Trouw L; Verstappen S
Lancet; 2015 Feb; 385 Suppl 1():S44. PubMed ID: 26312866
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for oral methotrexate failure in patients with inflammatory polyarthritis: results from a UK prospective cohort study.
Bluett J; Sergeant JC; MacGregor AJ; Chipping JR; Marshall T; Symmons DPM; Verstappen SMM
Arthritis Res Ther; 2018 Mar; 20(1):50. PubMed ID: 29554956
[TBL] [Abstract][Full Text] [Related]
18. The NOAR Damaged Joint Count (NOAR-DJC): a clinical measure for assessing articular damage in patients with early inflammatory polyarthritis including rheumatoid arthritis.
Bunn DK; Shepstone L; Galpin LM; Wiles NJ; Symmons DP
Rheumatology (Oxford); 2004 Dec; 43(12):1519-25. PubMed ID: 15316124
[TBL] [Abstract][Full Text] [Related]
19. Serum complement C3 correlates with insulin resistance in never treated psoriatic arthritis patients.
Ursini F; Grembiale A; Naty S; Grembiale RD
Clin Rheumatol; 2014 Dec; 33(12):1759-64. PubMed ID: 24005838
[TBL] [Abstract][Full Text] [Related]
20. Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study.
Ajeganova S; Andersson ML; Frostegård J; Hafström I
J Rheumatol; 2013 Dec; 40(12):1958-66. PubMed ID: 23950188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
